We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Does the Association Between TMEM98 and Nanophthalmos Require Further Confirmation?—Reply

Mona S. Awadalla, MBBS, PhD1; Kathryn P. Burdon, PhD2; Jamie E. Craig, MBBS, DPhil, FRANZCO1
[+] Author Affiliations
1Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
2Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia
JAMA Ophthalmol. 2015;133(3):359-360. doi:10.1001/jamaophthalmol.2014.4919.
Text Size: A A A
Published online


In Reply We agree with Sun and Zhang that the association of TMEM98 with nanophthalmos1 requires further confirmation, ideally by identifying additional pathogenic mutations in families who have nanophthalmos with a similar phenotype combined with molecular evidence of gene dysfunction. However, the identification of variants in individuals with different phenotypes as reported in the letter by Sun and Zhang in no way discounts TMEM98 as the likely cause of nanophthalmos in the reported family. Sequencing this gene in a large number of patients with phenotypes similar to the reported family would be a more useful strategy to determine its contribution to nanophthalmos and related phenotypes.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





March 1, 2015
Wenmin Sun, MD, PhD; Qingjiong Zhang, MD, PhD
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
JAMA Ophthalmol. 2015;133(3):358-359. doi:10.1001/jamaophthalmol.2014.4915.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...